Dhruv Jani sells 10L Global Longlife shares, stake drops to 6.89%
Dhruv Sureshkumar Jani, a promoter of Global Longlife Hospital and Research Limited, sold 10,00,000 equity shares on the BSE between August 06 and August 07, 2026. His stake decreased from 16.41% to 6.89%. The transaction was disclosed under SEBI Regulation 29(2) on August 08, 2026.

*this image is generated using AI for illustrative purposes only.
Promoter Dhruv Sureshkumar Jani has significantly reduced his stake in Global Longlife Hospital and Research Limited , selling 10,00,000 equity shares through open market transactions. The sale, which took place between August 06, 2026, and August 07, 2026, brings his total holding down from 16.41% to 6.89% of the company’s voting capital. This disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, notifying the Bombay Stock Exchange of the change in shareholding pattern.
The transaction represents a substantial reduction in promoter ownership, with the sale accounting for 9.52% of the total diluted share and voting capital. Prior to the sale, Jani held 17,22,990 shares carrying voting rights. Following the disposal, his remaining holding stands at 7,22,990 shares. The company’s total equity share capital remains unchanged at ₹10,50,00,000, comprising 1,05,00,000 equity shares of ₹10 each.
Transaction Details
The following table outlines the change in shareholding before and after the sale:
| Metric | Before Sale | Shares Sold | After Sale |
|---|---|---|---|
| Shares with voting rights | 17,22,990 | 10,00,000 | 7,22,990 |
| Stake percentage | 16.41% | 9.52% | 6.89% |
Jani, who is part of the promoter group, executed the sales via the open market mechanism. No voting rights were acquired or sold otherwise than by shares, and there were no warrants, convertible securities, or other instruments entitling the seller to receive shares carrying voting rights involved in this transaction. Similarly, no shares were encumbered by pledge, lien, or non-disposal undertaking at the time of filing.
Regulatory Compliance
The disclosure was submitted to BSE Limited on August 08, 2026, adhering to the mandatory reporting requirements for substantial shareholders. The filing confirms that the seller belongs to the promoter/promoter group and lists the specific dates of acquisition and sale as August 06, 2026, to August 07, 2026. The company’s total diluted share/voting capital after the sale is not applicable, as indicated in the regulatory format. This reduction in promoter stake may be monitored by investors for potential implications on corporate governance and control dynamics within the organization.
Historical Stock Returns for Global Longlife Hospital & Research
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.98% | +5.90% | +18.91% | -8.36% | -43.30% | -90.85% |
What strategic reasons might drive promoter Dhruv Sureshkumar Jani to reduce his stake from 16.41% to 6.89% in such a short timeframe?
How could this significant drop in promoter holding impact investor confidence and the stock price of Global Longlife Hospital and Research Limited?
Does the reduction in stake below 10% trigger any changes in corporate governance requirements or control dynamics for the company?


































